Literature DB >> 7263104

Oxytropium bromide in bronchial asthma: comparison of metered dose inhaler and powder inhalation of the anticholinergic bronchodilator oxytropium bromide in protection against acetylcholine and histamine provocation.

H M Beumer, C Grieben, C Schuijt, J Siebelink.   

Abstract

A marked protective effect of 0.2 mg oxytropium bromide (Ba 253), administered by inhalation, was observed against experimental provocation with a 3% acetylcholine solution. There is no difference between application by means of a metered dose inhaler or by means of powder inhalation. There is no marked protective effect of 0.2 mg oxytropium bromide administered by inhalation (aerosol or powder) against experimental provocation with a 0.3% histamine solution.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263104

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  2 in total

1.  Application of a radioreceptor assay in a pharmacokinetic study of oxitropium bromide in healthy volunteers after single i.v., oral and inhalation doses.

Authors:  K Ensing; R A de Zeeuw; W G in 't Hout; P J Cornelissen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Bronchodilator effects of oxitropium bromide, fenoterol, and their combination in normal subjects.

Authors:  M Fujimura; Y Kamio; T Matsuda; T Hashimoto
Journal:  Clin Auton Res       Date:  1993-02       Impact factor: 4.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.